Nuclera Partners with Solve Scientific to Expand eProtein Discovery Platform Access in Australia and New Zealand
核心洞察
Nuclera (搜索) has signed a partnership agreement with Solve Scientific (搜索) to distribute its eProtein Discovery (搜索)™ platform across Australia and New Zealand, expanding access to the company's rapid protein production technology.
The eProtein Discovery (搜索)™ System combines digital microfluidics, in situ protein detection assays, and cell-free protein synthesis to produce purified proteins in under 48 hours, compared to months required by traditional methods.
This partnership targets the rapidly growing Asia-Pacific recombinant protein market, which is projected to reach $1.46 billion by 2030 with an 11.7% compound annual growth rate.
Cambridge-based biotechnology company Nuclera (搜索) has announced a strategic partnership with Solve Scientific (搜索) Australia to expand access to its eProtein Discovery (搜索)™ platform across Australia and New Zealand. The collaboration marks the latest milestone in Nuclera's global expansion strategy, targeting the rapidly growing Asia-Pacific protein production market.
Targeting High-Growth Market Opportunity
The partnership addresses significant market demand in the Asia-Pacific region, where the recombinant protein market is experiencing exceptional growth. According to market projections, the Asia-Pacific recombinant protein market is anticipated to reach approximately $1.46 billion in revenue by 2030, representing a compound annual growth rate of 11.7 percent.
"This partnership follows our establishment of a distribution network across APAC and the Middle East earlier this year," said Joseph Bertelsen, Chief Commercial Officer at Nuclera (搜索). "Partnering with Solve Scientific (搜索) supports our long-term goal of global expansion and further strengthens our presence in the rapidly expanding APAC market, expanding our distribution network to reach even more customers in this region."
Revolutionary Protein Production Technology
Nuclera (搜索)'s eProtein Discovery (搜索)™ System represents a significant advancement in protein production methodology, combining digital microfluidics, in situ protein detection assays, and cell-free protein synthesis to automate key stages of the protein production workflow. The platform dramatically reduces both time and cost involved in producing functional proteins, which is crucial for drug discovery applications.
The system streamlines construct screening, protein scale-up, and purification processes, enabling researchers to acquire purified proteins ready for functional testing in under 48 hours. This represents a substantial improvement over traditional cell-based protein expression methods, which typically require several months to deliver comparable results.
Local Expertise and Support
Through the partnership with Solve Scientific (搜索), Nuclera (搜索) aims to provide localized support, technical expertise, and streamlined access to its technology for researchers working in drug discovery and biotechnology research across Australia and New Zealand.
"We are excited to introduce Nuclera (搜索)'s eProtein Discovery (搜索)™ platform to ANZ researchers for accessing challenging proteins," said Shaun Brooks, Managing Director at Solve Scientific (搜索). "This unique cutting-edge technology enhances efficiency and de-risks early-stage discovery. We look forward to working with our research community, together with Nuclera's expertise, to demonstrate how this technology can transform drug discovery projects."
Accelerating Drug Discovery Workflows
The eProtein Discovery (搜索)™ platform's ability to produce results in days rather than months provides scientists with a powerful tool for advancing research and accelerating early-stage drug development. By automating traditionally labor-intensive processes, the technology enables researchers to focus on functional testing and downstream applications more quickly.
This partnership continues Nuclera (搜索)'s mission to make protein science faster, more accessible, and more reliable for the global research community. The collaboration with Solve Scientific (搜索) is expected to strengthen support for researchers across the Australia and New Zealand region while driving innovation in the biotechnology and pharmaceutical sectors.